Cancer Institute Clinical Trials Lymphoma-Leukemia-Myeloma

Myeloma

#130437 NCT01564537
Title:
Tourmaline-MM2 Protocol C16014: A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma
Study Location:
Temple Main Campus

For more information or to enroll in a study, please call 254-724-5407.


Print
Text Size
A
A
A